Catalog ID
PTL-EXN4
Exendin-4
Exenatide
Exendin-4 (Exenatide), a GLP-1 receptor agonist investigated in glucose-dependent insulin secretion and metabolic research models.
Molecular Formula
C184H282N50O60S (reported)
Formula reported in literature; verify against COA.
Purity
≥98%
Molecular Weight
4186.6 g/mol (reported)
Classification
GLP-1 receptor agonist (incretin mimetic)
Price
$120.00 – $980.00 USD
Indicative range · converted from USD · free shipping from €500
Pricing tiers · mass & purity
1 mg
$120.00
≥98%
5 mg
$480.00
≥98%
10 mg
$980.00
≥98%
Scientific Background
Exendin-4 (Exenatide) is a GLP-1 receptor agonist first isolated from Gila monster venom. It is studied in glucose-dependent insulin secretion and metabolic signaling research. Molecular values are reported in literature and should be verified against the certificate of analysis.
Research Focus — Pathways
GLP-1 receptor signaling; cAMP-mediated insulin secretion pathways.
Research Areas
- Glucose regulation
- Insulin signaling
- GLP-1 receptor signaling
- Metabolic research
Molecular Formula
C184H282N50O60S (reported)
Formula reported in literature; verify against COA.
Molecular Weight
4186.6 g/mol (reported)
Amino Acid Sequence
HGEGTFTSDLSKQMEEEAVRLFIEWLKNGGPSSGAPPPS-NH2 (reported)
Classification
GLP-1 receptor agonist (incretin mimetic)
Research Format
Lyophilized research reagent
Purity
≥98%
Peptide Classification
GLP-1 receptor agonist (incretin mimetic)
Sequence Notation
HGEGTFTSDLSKQMEEEAVRLFIEWLKNGGPSSGAPPPS-NH2 (reported)
Scientific References
The following authoritative sources provide peer-reviewed literature on Exendin-4. Peptide Hub Biotech World Wide does not claim these sources endorse this product.
Exenatide — PubChem compound data
PubChem
https://pubchem.ncbi.nlm.nih.gov/#query=ExenatideExendin-4 / GLP-1 — PubMed literature
PubMed / NCBI
https://pubmed.ncbi.nlm.nih.gov/?term=exendin-4
Exendin-4 — frequently asked
What is Exendin-4 used for in research?
Exendin-4 (Exenatide) is investigated in glucose regulation, insulin signaling, glp-1 receptor signaling, metabolic research research. Exendin-4 (Exenatide) is a GLP-1 receptor agonist first isolated from Gila monster venom. It is studied in glucose-dependent insulin secretion and metabolic signaling research. Molecular values are reported in literature and should be verified against the certificate of analysis.
What purity and documentation does Exendin-4 include?
Exendin-4 is supplied at ≥98% reported purity as a Lyophilized research reagent. A Certificate of Analysis (COA) is available on request with every order.
Does Peptide Hub Biotech World Wide ship Exendin-4 to the USA, Canada, Europe, Australia and New Zealand?
Yes. Peptide Hub Biotech World Wide ships Exendin-4 to research customers in the United States, Canada, across Europe, Australia, New Zealand and South American markets. Bulk and wholesale quotes are available via the contact form.
How can I order Exendin-4?
Order directly from each product page via our Bitcoin (BTC) checkout — there is no minimum order, and shipping is free on orders from €500 (converted to your local currency). For bulk or wholesale quantities, request a quote through the contact form. After payment, confirm your transaction by email and shipping will proceed.
Related Products
Metabolic & Endocrine99.2%GLP-1 Receptor Agonists
Glucagon-like peptide-1 receptor agonists studied in metabolic and glucose-regulation research.
Metabolic & Endocrine99.91%Glucagon (1-29)
Pancreatic peptide hormone studied in gluconeogenesis and glucose-regulation research.
Metabolic & Endocrine99.92%Insulin (human)
Polypeptide hormone regulating glucose, studied in metabolic and diabetes-related research.
QC & Quality Systems
Every lot is verified by HPLC and mass-spectrometry purity analysis, peptide-content determination and residual-solvent testing, with a Certificate of Analysis issued per batch — aligned to ISO 9001:2015 and ISO 13485:2016 quality systems, with FDA Drug Master File (DMF) and MDSAP regulatory pathways supported.
ISO 9001:2015
Quality Management System
ISO 13485:2016
Medical Device QMS
FDA DMF
Drug Master File
MDSAP
Medical Device Single Audit Program
Quality & Documentation
Certificate of Analysis available on request · Research Use Only
Request a Quote